{"name":"Heather Wakelee","slug":"heather-wakelee","ticker":"","exchange":"","domain":"","description":"Heather A. Wakelee is a professor of oncology at Stanford University Medical Center. Her research focuses on lung cancer.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Folate","genericName":"Folate","slug":"folate","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Folate","genericName":"Folate","slug":"folate","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNM0dpT1NkV3pJQlZPWWUzSndBdFN2aUtuWjhIc3hjNDFXNEpkNUw3d3JRMXU0U0NQT2MyWm1hTUdHSUE5V2UxWUhTc2ZQUTVlV0plNDNON0xjamlLeENMbnlnX0ZOdXk3VHVBNmItMUpTTFgza1hhYzB4ZlVOS245emlOWUVkZnZMX3VVdlpmYmJYaTFDek1sWGZUR18tVHM2Q0tLdHRqNA?oc=5","date":"2026-03-26","type":"pipeline","source":"ASCO Daily News","summary":"What Is the Role of Liquid Biopsy in Monitoring the Efficacy of Targeted Therapy in Advanced NSCLC? - ASCO Daily News","headline":"What Is the Role of Liquid Biopsy in Monitoring the Efficacy of Targeted Therapy in Advanced NSCLC?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOWFdCNnNJa1BMaUFkVHlXY1FtUlVnOUpkQ0U5Nkg1STA5NEZoZWk0LVZLVVp2M1Q1MU9XS202NDE2U1ZES2tKaEM0RXdHamUyU1JEYU50SWlHcGI0MV9lYUFwY0VZUDVSdk5uRDFVMnQwOUY3OUNRWDRYemV3T29QcWNscnFGM1VQUUVCc0NB?oc=5","date":"2023-10-16","type":"regulatory","source":"pharmaphorum","summary":"AZ’s Tagrisso plus chemo get fast FDA review for lung cancer - pharmaphorum","headline":"AZ’s Tagrisso plus chemo get fast FDA review for lung cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNeHZrdEZhTTdmaWJ4ZnZNT1ZldTJjeGtxZl9CU1FRQjc1cVpxSFZJUHBMYl8zX3ZJR1NlTG92R09pVVg2T1VlRGlaeFZ4SGJwYm83QzU4ejZKQXZNRHdHcVNXN2M2TW9ZWmJVUFhpWk1zMlloQUVPSG1FNHlsTjA3RUk3Z0M5VEVBd2c3V2VPcmpZdko0UmQ3bVpDNFdHTHFQX2p5T3BLRjZmM0lwS3N1TVhlYm00UVVnQlJLNW9ZbnZpVjJf?oc=5","date":"2023-08-15","type":"pipeline","source":"Hospital Pharmacy Europe","summary":"Perioperative pembrolizumab improves outcomes in early-stage NSCLC - Hospital Pharmacy Europe","headline":"Perioperative pembrolizumab improves outcomes in early-stage NSCLC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOU3dLc1hjMkEyZHVkY3pLTDIwSExObFd4cFVjZ0ZDLVgxdm5UNWMzMGJ1empTSnowNFFzSUVHT3hmNFJxbzZWZFFURVpwX25nM3B0Q0FMejQ0Snl4bzdOWEs3UTduUVJUaHpYbTJuRndYYThldEp3cFhhdFR2WVZkQkt3a09tTzRpejlmQkkwTW5QaWwxZTFzaWpMZ0tVWGpqaHFLeDBYSDJQQjZodklnUHdwblNfNEl4cEpz?oc=5","date":"2023-06-03","type":"pipeline","source":"Fierce Pharma","summary":"ASCO: Merck bills Keytruda, used around surgery, as new standard in 'messy' early lung cancer realm - Fierce Pharma","headline":"ASCO: Merck bills Keytruda, used around surgery, as new standard in 'messy' early lung cancer realm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE5EU3VxOUozUjQyMm9WcDV4M1h1RFotV0cyS0V1RVEwX1FWNlRjRlpxcUN4M0hLZ0Y3amFmaDU4QXg4MlphNzNYNGREMi1vWklDQlpfaF9aYWJCN0NjWXlyem1VNA?oc=5","date":"2021-03-16","type":"pipeline","source":"JACC Journals","summary":"Myocarditis Surveillance With High-Sensitivity Troponin I During Cancer Treatment With Immune Checkpoint Inhibitors - JACC Journals","headline":"Myocarditis Surveillance With High-Sensitivity Troponin I During Cancer Treatment With Immune Checkpoint Inhibitors","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}